Robin mansukhani
ceo Deciduous Therapeutics
Seminars
Wednesday 2nd December 2026
Targeting Senescent Cells & Injury Resolution Pathways to Remove Barriers to Fibrosis Reversal
4:15 pm
- Understanding how senescent cells perpetuate pro-fibrotic signaling & prevent resolution even after initial injury removal
- Evaluating senolytic & senostatic approaches to eliminate or reprogram senescent cell populations in fibrotic tissues
- Assessing early clinical evidence for senescence-targeted therapies in promoting fibrosis regression across multiple organs
